Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Ou, Jie Ping ^a   Lin, Hsueh Yi ^b   Su, Kang Yi ^c,d   Yu, Sung Liang ^d   Tseng, I Hsuan ^e   Chen, Cheng Jueng ^f   Hsu, Hui Chen ^e   Chan, De Chuan ^f   Sophia Chen, Yi Lin ^e  

^a HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b Taipei Sports University   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL ILAN UNIVERSITY   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ISOCHAIHULACTONE; MYC PROTEIN; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL FATE; CONTROLLED STUDY; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84867766694     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/809204     Document Type: Article

References (34)

1. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C., Trends in alternative medicine use in the United States, 19901997: results of a follow-up national survey. Journal of the American Medical Association 1998 280 18 1569 1575 2-s2.0-0032508952 (Pubitemid 28520643)
2. Sippel R. S., Chen H., Carcinoid Tumors. Surgical Oncology Clinics of North America 2006 15 3 463 478 2-s2.0-33746373162 10.1016/j.soc.2006.05.002 (Pubitemid 44119207)
3. Lal A., Chen H., Treatment of advanced carcinoid tumors. Current Opinion in Oncology 2006 18 1 9 15 2-s2.0-33646265386 10.1016/j.apcata.2006.01.016 (Pubitemid 43740444)
4. Daniel V. C., Peacock C. D., Watkins D. N., Developmental signalling pathways in lung cancer. Respirology 2006 11 3 234 240 2-s2.0-33645997016 10.1111/j.1440-1843.2006.00838.x
5. Kunnimalaiyaan M., Traeger K., Chen H., Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. American Journal of Physiology 2005 289 4 G636 G642 2-s2.0-25444434095 10.1152/ajpgi.00146.2005 (Pubitemid 41377169)
6. Nakakura E. K., Sriuranpong V. R., Kunnimalaiyaan M., Hsiao E. C., Schuebel K. E., Borges M. W., Jin N., Collins B. J., Nelkin B. D., Chen H., Ball D. W., Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. Journal of Clinical Endocrinology and Metabolism 2005 90 7 4350 4356 2-s2.0-23044498449 10.1210/jc.2005-0540 (Pubitemid 41058218)
7. Kunnimalaiyaan M., Vaccaro A. M., Ndiaye M. A., Chen H., Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. Journal of Biological Chemistry 2006 281 52 39819 39830 2-s2.0-33845987566 10.1074/jbc.M603578200 (Pubitemid 46041785)
8. Kunnimalaiyaan M., Chen H., Tumor suppressor role of notch-1 signaling in neuroendocrine tumors. Oncologist 2007 12 5 535 542 2-s2.0-34548452775 10.1634/theoncologist.12-5-535 (Pubitemid 350012116)
9. Screpanti I., Bellavia D., Campese A. F., Frati L., Gulino A., Notch, a unifying target in T-cell acute lymphoblastic leukemia? Trends in Molecular Medicine 2003 9 1 30 35 2-s2.0-0037248329 10.1016/S1471-4914(02)00003-5 (Pubitemid 36139253)
10. Dievart A., Beaulieu N., Jolicoeur P., Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 1999 18 44 5973 5981 2-s2.0-0033613401 10.1038/sj.onc.1202991 (Pubitemid 29535009)
11. Axelson H., Notch signaling and cancer: emerging complexity. Seminars in Cancer Biology 2004 14 5 317 319 2-s2.0-3342986584 10.1016/j.semcancer.2004.04. 010 (Pubitemid 38993632)
12. Leong K. G., Karsan A., Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006 107 6 2223 2233 2-s2.0-33644782668 10.1182/blood-2005-08-3329 (Pubitemid 43345539)
13. Sriuranpong V., Borges M. W., Ravi R. K., Arnold D. R., Nelkin B. D., Baylin S. B., Ball D. W., Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Research 2001 61 7 3200 3205 2-s2.0-0035300448 (Pubitemid 32691976)
14. Klinakis A., Szaboks M., Politi K., Kiaris H., Artavanis-Tsakonas S., Efstratiadis A., Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9262 9267 2-s2.0-33745131039 10.1073/pnas.0603371103 (Pubitemid 43902566)
15. Chen Y., De Marco M. A., Graziani I., Gazdar A. F., Strack P. R., Miele L., Bocchetta M., Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Research 2007 67 17 7954 7959 2-s2.0-34548599785 10.1158/0008-5472.CAN-07-1229 (Pubitemid 47395124)
16. Zheng Q., Qin H., Zhang H., Li J., Hou L., Wang H., Zhang X., Zhang S., Feng L., Liang Y., Han H., Yi D., Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncology Reports 2007 17 4 847 852 2-s2.0-34249936877
17. Yin L., Velazquez O. C., Liu Z. J., Notch signaling: emerging molecular targets for cancer therapy. Biochemical Pharmacology 2010 80 5 690 701 2-s2.0-77954215506 10.1016/j.bcp.2010.03.026
18. Espinosa L., Cathelin S., D'Altri T., Trimarchi T., Statnikov A., Guiu J., Rodilla V., Inglés-Esteve J., Nomdedeu J., Bellosillo B., Besses C., Abdel-Wahab O., Kucine N., Sun S. C., Song G., Mullighan C. C., Levine R. L., Rajewsky K., Aifantis I., Bigas A., The Notch/Hes1 pathway sustains NF- κ B activation through CYLD repression in T cell leukemia. Cancer Cell 2010 18 3 268 281 2-s2.0-77956511912 10.1016/j.ccr.2010.08.006
19. Arumugam T. V., Cheng Y. L., Choi Y., Choi Y. H., Yang S., Yun Y. K., Park J. S., Yang D. K., Thundyil J., Gelderblom M., Karamyan V. T., Tang S. C., Chan S. L., Magnus T., Sobey C. G., Jo D. G., Evidence that γ -secretase-mediated notch signaling induces neuronal cell death via the nuclear factor- κ B-Bcl-2-interacting mediator of cell death pathway in ischemic stroke. Molecular Pharmacology 2011 80 1 23 31 2-s2.0-79959320245 10.1124/mol.111.071076
20. Henry T. R., The history of valproate in clinical neuroscience. Psychopharmacology bulletin 2003 37 5 16 2-s2.0-3242724333
21. Stockhausen M. T., Sjölund J., Manetopoulos C., Axelson H., Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. British Journal of Cancer 2005 92 4 751 759 2-s2.0-14944356392 10.1038/sj.bjc.6602309 (Pubitemid 40460614)
22. Greenblatt D. Y., Vaccaro A. M., Jaskula-Sztul R., Ning L., Haymart M., Kunnimalaiyaan M., Chen H., Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 2007 12 8 942 951 2-s2.0-34548463002 10.1634/theoncologist.12-8-942 (Pubitemid 47359136)
23. Platta C. S., Greenblatt D. Y., Kunnimalaiyaan M., Chen H., Valproic acid induces notch1 signaling in small cell lung cancer cells. Journal of Surgical Research 2008 148 1 31 37 2-s2.0-51749123773 10.1016/j.jss.2008.03.008
24. Cheng Y. L., Lee S. C., Lin S. Z., Chang W. L., Chen Y. L., Tsai N. M., Liu Y. C., Tzao C., Yu D. S., Harn H. J., Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Letters 2005 222 2 183 193 2-s2.0-18044382891 10.1016/j.canlet.2004.10. 015 (Pubitemid 40603645)
25. Chen Y. L., Lin S. Z., Chang W. L., Cheng Y. L., Harn H. J., Requirement for ERK activation in acetone extract identified from Bupleurrum scorzonerifolium induced A549 tumor cell apoptosis and keratin 8 phosphorylation. Life Sciences 2005 76 21 2409 2420 2-s2.0-14844317349 10.1016/j.lfs.2004.09.044 (Pubitemid 40341958)
26. Chen Y. L., Lin S. Z., Chang J. Y., Cheng Y. L., Tsai N. M., Chen S. P., Chang W. L., Harn H. J., In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Biochemical Pharmacology 2006 72 3 308 319 2-s2.0-33745649582 10.1016/j.bcp.2006.04.031 (Pubitemid 43975083)
27. Chen Y. L., Lin P. C., Chen S. P., Lin C. C., Tsai N. M., Cheng Y. L., Chang W. L., Lin S. Z., Harn H. J., Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. Journal of Pharmacology and Experimental Therapeutics 2007 323 2 746 756 2-s2.0-35548995873 10.1124/jpet.107.126193 (Pubitemid 350005118)
28. Wang Q., Tang X. N., Yenari M. A., The inflammatory response in stroke. Journal of Neuroimmunology 2007 184 1-2 53 68 2-s2.0-33847644971 10.1016/j.jneuroim.2006.11.014 (Pubitemid 46365991)
29. Van Engeland M., Nieland L. J. W., Ramaekers F. C. S., Schutte B., Reutelingsperger C. P. M., Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998 31 1 1 9 (Pubitemid 28050057)
30. Guillot C., Falette N., Paperin M. P., Courtois S., Gentil-Perret A., Treilleux I., Ozturk M., Puisieux A., p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours. Oncogene 1997 14 1 45 52 2-s2.0-0031027257 (Pubitemid 27042954)
31. Bulavin D. V., Higashimoto Y., Demidenko Z. N., Meek S., Graves P., Phillips C., Zhao H., Moody S. A., Appella E., Piwnica-Worms H., Fornace A. J., Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nature Cell Biology 2003 5 6 545 551 2-s2.0-0037804567 10.1038/ncb994 (Pubitemid 36781089)
32. Gould K. L., Nurse P., Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 1989 342 6245 39 45 2-s2.0-0024959919
33. Lammer C., Wagerer S., Saffrich R., Mertens D., Ansorge W., Hoffmann I., The cdc25B phosphatase is essential for the G2/M phase transition in human cells. Journal of Cell Science 1998 111 16 2445 2453 2-s2.0-0031669731 (Pubitemid 28434930)
34. Singh R. P., Agrawal P., Yim D., Agarwal C., Agarwal R., Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 2005 26 4 845 854 2-s2.0-17844364904 10.1093/carcin/bgi014 (Pubitemid 41214348)